- Home
- FOA vs ATYR Comparison
FOA vs ATYR Comparison
Compare FOA & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOA
- ATYR
- Stock Information
- Founded
- FOA 2013
- ATYR 2005
- Country
- FOA United States
- ATYR United States
- Employees
- FOA N/A
- ATYR N/A
- Industry
- FOA Finance Companies
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FOA Finance
- ATYR Health Care
- Exchange
- FOA Nasdaq
- ATYR Nasdaq
- Market Cap
- FOA 240.8M
- ATYR 228.1M
- IPO Year
- FOA N/A
- ATYR 2015
- Fundamental
- Price
- FOA $26.42
- ATYR $3.52
- Analyst Decision
- FOA Hold
- ATYR Strong Buy
- Analyst Count
- FOA 1
- ATYR 5
- Target Price
- FOA $24.00
- ATYR $19.25
- AVG Volume (30 Days)
- FOA 222.7K
- ATYR 960.8K
- Earning Date
- FOA 03-05-2025
- ATYR 03-13-2025
- Dividend Yield
- FOA N/A
- ATYR N/A
- EPS Growth
- FOA N/A
- ATYR N/A
- EPS
- FOA 10.89
- ATYR N/A
- Revenue
- FOA $719,526,000.00
- ATYR $235,000.00
- Revenue This Year
- FOA N/A
- ATYR N/A
- Revenue Next Year
- FOA N/A
- ATYR $1,080.92
- P/E Ratio
- FOA $2.51
- ATYR N/A
- Revenue Growth
- FOA 3011.46
- ATYR N/A
- 52 Week Low
- FOA $4.10
- ATYR $1.42
- 52 Week High
- FOA $32.40
- ATYR $4.23
- Technical
- Relative Strength Index (RSI)
- FOA 53.66
- ATYR 52.84
- Support Level
- FOA $24.01
- ATYR $3.46
- Resistance Level
- FOA $27.93
- ATYR $3.83
- Average True Range (ATR)
- FOA 2.61
- ATYR 0.24
- MACD
- FOA -0.49
- ATYR -0.02
- Stochastic Oscillator
- FOA 40.32
- ATYR 41.04
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to an range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.